Rucci Carolyn M.
SVP, Chief Legal Officer
Rucci Carolyn M. has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Feb 4, 2026.
On the most recent filing, Rucci Carolyn M. is listed as SVP, Chief Legal Officer at Akebia Therapeutics, Inc. Inside the rolling window, Rucci Carolyn M. reported no open-market purchases and 1 open-market sale totaling $97K in AKBA.
Companies traded
Other insiders at AKBA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$97K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Rucci Carolyn M. made?
Rucci Carolyn M. has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Rucci Carolyn M. trade?
Rucci Carolyn M. has filed SEC Form 4 disclosures for 1 company, including AKBA.
When was Rucci Carolyn M.'s most recent SEC Form 4 filing?
Rucci Carolyn M.'s most recent SEC Form 4 filing on Tracefour is dated Feb 4, 2026.
What is Rucci Carolyn M.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Rucci Carolyn M. is listed as SVP, Chief Legal Officer.
What is Rucci Carolyn M.'s total buy and sell value in the current window?
Inside the rolling retention window, Rucci Carolyn M. bought $0 and sold $97K based on SEC Form 4 filings.
What was Rucci Carolyn M.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 69,772 AKBA shares on 2026-02-02, worth $97K, per SEC Form 4 filings.